Elisa Biasco

Livorno, 57124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma.

Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma.

Journal: Cancers

Published: December 21, 2025

Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival.

Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival.

Journal: Oncology research

Published: September 25, 2025

Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.

Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.

Journal: Future oncology (London, England)

Published: January 29, 2021

Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.

Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 01, 2019

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer.

Journal: Future oncology (London, England)

Published: March 20, 2019

The effect of a treatment delay on outcome in metastatic renal cell carcinoma.

The effect of a treatment delay on outcome in metastatic renal cell carcinoma.

Journal: Urologic oncology

Published: October 05, 2018

A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinoma.

A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinoma.

Journal: Tumori

Published: June 14, 2018

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.

Journal: Anti-cancer drugs

Published: May 31, 2018

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.

Journal: Anticancer research

Published: May 22, 2018

Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680-7.

Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680-7.

Journal: European urology

Published: July 20, 2017

Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.

Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.

Journal: Critical reviews in oncology/hematology

Published: July 17, 2017

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

Journal: Urologic oncology

Published: November 28, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026